Search USGSSearch

USGS · 70266052

Disease, environment, and pollution: Understanding drivers behind tumour outbreaks in sea turtles

Abstract

Various wildlife diseases of the Anthropocene (the Anthropocene currently has no formal status in the Divisions of Geologic Time https://pubs.usgs.gov/fs/2018/3054/fs20183054.pdf , accessed 4 June 2024) have root causes that are found in human-driven environmental disturbances. Fibropapillomatosis of sea turtles is exemplary of a human-exacerbated wildlife disease, and this case study offers an overview of how we applied a One Health approach and interdisciplinary process to better understand its complexity and highlight the interconnections existing between the health of the environment, and of the wildlife and humans living in it. Persistent organic pollutants (POPs) have known detrimental effects on human and wildlife health. Ubiquitous in the environment, these degradation-resistant chemicals have a high bioaccumulation potential. This case study describes the interdisciplinary plan and One Health design implemented to measure the role of harmful pollutants in the occurrence of a marine turtle panzootic fibropapillomatosis (FP). FP is a neoplastic disease that causes the growth of debilitating tumours on soft tissues and internal organs. Disease incidence has been increasing significantly throughout the Anthropocene and the reasons are still uncertain. The pervasive effect of pollution in marine coastal habitats has often been hypothesized as a driver of high disease prevalence but never fully tested. Our project combines disease ecology, marine field biology, and chemical toxicology in the attempt to unravel the intricate dynamics behind FP. We here describe the complex process used to develop a methodology to measure levels of harmful seawater pollutants such as polychlorinated biphenyls (PCBs), polycyclic aromatic hydrocarbons (PAHs), and organochlorine pesticides (OCPs) in important sea turtle habitats in Florida. The proposed contaminants are among the top priority harmful pollutants, highly carcinogenic in aquatic animals, and bioaccumulate in sea turtles. Although only providing a description of the methodological process, this case study can help future research to apply similar transdisciplinary studies in the context of wildlife diseases. Understanding the effects of anthropogenic-driven pollution activity on ocean health can clarify its consequences to the health of wildlife and humans living in and around that environment.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Costanza Manes, Richard M. Herren, Evan Cooper, Margaret Lilyestrom, David Godfrey, Marianne Kuzoch, Raymond R. Carthy, Ilaria Capua. 2025-01-16. Disease, environment, and pollution: Understanding drivers behind tumour outbreaks in sea turtles. https://doi.org/10.1079/onehealthcases.2025.0001

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related USGS reports

One Health best practice case study: Advancing national One Health coordination in the United States through the One Health zoonotic disease prioritization process

The U.S. government advances One Health coordination through the best practices of jointly developing shared priorities and utilizing formalized coordination platforms to connect partners from public health, agriculture, wildlife, environment, and other sectors at the national, subnational (e.g. state, tribal, local, and territorial), and non-governmental levels (e.g. academia, industry, non-governmental organizations, and the public) levels. Coordinated efforts were strengthened through the U.S. One Health Zoonotic Disease Prioritization (OHZDP) workshop in 2017, which led to the prioritization of eight zoonotic diseases and development of next steps and action plans for One Health collaboration across federal agencies (Prioritizing Zoonotic Diseases for Multisectoral, One Health Collaboration in the United States, 2017). This One Health best practice was used to prioritize the top endemic and emerging zoonoses of greatest concern for the United States, identify gaps, and define plans for U.S. government One Health collaboration to address the priority zoonotic diseases. Multiple actions that strengthened One Health coordination were enacted, including establishing the One Health Federal Interagency COVID-19 Coordination (OH-FICC) group. To further advance One Health in the United States, Congress mandated that the U.S. Centers for Disease Control and Prevention, the Department of the Interior, and the U.S. Department of Agriculture collaborate to develop the National One Health Framework to Address Zoonotic Diseases and Advance Public Health Preparedness in the United States as well as formalize a One Health, multisectoral coordination mechanism, the United States One Health Coordination Unit at the federal level (Appropriations Committee Report, 2021; Consolidated Appropriations Act, 2023). Enhancing national level One Health coordination in the United States has also helped advance collaboration with subnational and non-governmental levels to address timely One Health issues.

One Health Cases